22 जुलाई से संसद का बजट सत्र शुरू होने जा रहा है। वित्त मंत्री निर्मला सीतारमण मोदी सरकार के तीसरे कार्यकाल का पहला पूर्णकालिक बजट 23 जुलाई को पेश करने जा रही हैं। बजट पर तमाम विशेषज्ञों की ओर से प्रतिक्रिया देखने को मिल रही है। थैलेसीमिया रोगी वकालत समूह की सदस्य सचिव अनुभा तनेजा मुखर्जी ने कहा कि सरकार को निश्चित रूप से थैलेसीमिया की रोकथाम, प्रबंधन और उपचार के लिए खर्च बढ़ाने पर विचार करना चाहिए और रक्त विकार के लिए राष्ट्रीय स्तर पर नियंत्रण कार्यक्रम स्थापित करना चाहिए।

#unionbudget2024 #budget2024 #financeminister #nirmalasitharaman

Category

🗞
News
Transcript
00:00I would like to recommend that ahead of Union Budget 2025, the government should definitely
00:07consider spending, increase the spending on thalassemia, which is a disability under
00:14Rights of Persons with Disabilities Act 2016. It is also a hemoglobinopathy, so the government
00:21should increase the spending for prevention, management and treatment of thalassemia.
00:28As far as prevention is concerned, we really request Honorable FM to take up a national
00:35level control program for thalassemia on the lines of sickle cell anemia, because thalassemia is not
00:42different from sickle cell in terms of its impact. India is the thalassemia capital of
00:47the world and we should definitely spend to change that. In terms of management, the need of the hour
00:54is blood safety for patients of thalassemia because they are dependent on blood for survival.
01:01They have to take blood every 15 days, 20 days. So, spending on technologies like nucleic acid
01:09test, which is a gold standard for blood screening and prevents transfusion transmitted infections
01:16like HIV, HCV. This should be really considered and the government should consider mandating that
01:24spending on NAT, procuring NAT in the blood banks, at least in government hospitals and no patient
01:31should be given blood that is not NAT tested. Similarly, spending on voluntary blood donation
01:37or awareness programs should definitely increase. That's also one of the ways to ensure safe blood.
01:44Also, in terms of management, GST on life saving drugs for thalassemia patients like
01:52desferoxamine, death free prone and other drugs should be waived and also on equipment that is
01:59used for management of thalassemia like infusion pump. As far as treatment is concerned, we would
02:06urge the government, we would urge Honorable FM Madam to please consider giving unprecedented
02:14and unparalleled budget for research and innovation. We call ourselves the pharmacy of the
02:21world. So, we should definitely not lag behind when it comes to, you know, solutions like gene
02:27therapy, CRISPR gene editing, etc. It is not possible for Indians to do this globally. So,
02:36we should have our indigenous versions of gene therapy for treatment of thalassemia.
02:42Those would be our recommendations for thalassemia patients.

Recommended